What is LOPJLB’s current signal on OTLK?

LOPJLB’s latest quantitative signal on Outlook Therapeutics, Inc. (OTLK) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is OTLK in?

Outlook Therapeutics, Inc. (OTLK) is currently classified in the CRISIS HMM market regime on LOPJLB.

Where is Outlook Therapeutics, Inc. based / listed?

Outlook Therapeutics, Inc. is based in US, listed on NASDAQ.

Outlook Therapeutics, Inc. (OTLK)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$0.60+7.14%Close

SELLCRISIS · day 10

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $25M
Beta: 0.75
P/E (TTM): -0.31

Short % float: 118.41%
Days to cover: 7.1
SI change: -1.0%

1W: +1.69%
1M: -9.09%

vs SPY 1W: +0.53%
vs SPY 1M: -12.08%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Outlook Therapeutics, Inc. is a biopharmaceutical company in the advanced stages of clinical development, focused on inventing and bringing to market monoclonal antibody treatments for various eye conditions. Its flagship drug candidate, ONS-5010, is an ophthalmic formulation…

Employees: 17
Headquarters: US
Founded: 2016
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 41.1M
Float: 65.5%

outlooktherapeutics.com ↗

Key executives

Robert Charles Jahr — President, Chief Executive Officer & Director

Lawrence A. Kenyon — EVP, CFO, Treasurer, Secretary & Director

Jennifer Kissner — Senior Vice President of Clinical Development & Regulatory Affairs

SEC filings

EDGAR · CIK 16499890 · OTLK

Analyst consensus

Buy

Bullish857.1%

Neutral642.9%

Bearish00.0%

L $1.60Avg $2.80H $4.00

Target$2.80+366.67%

Last$0.60

Key stats

Prediction markets

Company news